Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease - Clinical Therapeutics
Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease
Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease - Clinical Therapeutics
Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique - ScienceDirect
Step-closer to nasal spray drug delivery for Parkinson's disease - News and events, University of York
FDA Approves Inhaled Levodopa for Parkinson's | MedPage Today
Nasal spray gel directly delivers Parkinson's drugs to the brain
Chemical structures of the analytes. (A) Levodopa, (B) carbidopa, (C)... | Download Scientific Diagram
Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease - Clinical Therapeutics
Inbrija indicated for OFF Episodes in Parkinson's Disease Patients, USA
Step-Closer to Nasal Spray Drug Delivery for Parkinson's Disease - Neuroscience News
Nasal Gel Boosts Delivery of MS Drug Levodopa to Brain: Mouse Study
Simultaneous determination of levodopa, carbidopa, entacapone, tolcapone, 3-O-methyldopa and dopamine in human plasma by an HPLC–MS/MS method | Bioanalysis
Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson's Disease
A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periods - ScienceDirect
Levodopa microparticles for pulmonary delivery: photodegradation kinetics and LC stability-indicating method
Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique - ScienceDirect
Interaction Studies Between Levodopa and Different Excipients to Develop Coground Binary Mixtures for Intranasal Application - Journal of Pharmaceutical Sciences
Potentials and challenges of Levodopa particle formulation for treatment of Parkinson's disease through intranasal and pulmonary delivery - ScienceDirect
Treating Parkinson's with Carbidopa/Levodopa – Journey with Parkinson's
A Step Towards a Nasal Spray Treatment for Parkinson's Disease | Technology Networks
Inbrija indicated for OFF Episodes in Parkinson's Disease Patients, USA
One step closer to nasal spray drug delivery for Parkinson's disease